11:18 AM EDT, 07/19/2024 (MT Newswires) -- Valerie Morisset, Executive Vice President, Research & Development, and Chief Scientific Officer, on July 17, 2024, sold 41,783 shares in Eliem Therapeutics ( ELYM ) for $289,492. Following the Form 4 filing with the SEC, Morisset has control over a total of 160,523 shares of the company, with 160,523 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1768446/000141588924019814/xslF345X03/form4-07192024_030734.xml
Price: 6.95, Change: +0.18, Percent Change: +2.66